» Articles » PMID: 15109023

Nanoparticle Engineering Processes for Enhancing the Dissolution Rates of Poorly Water Soluble Drugs

Overview
Publisher Informa Healthcare
Specialty Pharmacology
Date 2004 Apr 28
PMID 15109023
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Poor water solubility is an industry wide issue, especially for pharmaceutical scientists in drug discovery and drug development. In recent years, nanoparticle engineering processes have become promising approaches for the enhancement of dissolution rates of poorly water soluble drugs. Nanoparticle engineering enables manufacturing of poorly water soluble drugs into nanoparticles alone, or incorporation with a combination of pharmaceutical excipients. The use of these processes has dramatically improved in vitro dissolution rates and in vivo bioavailabilities of many poorly water soluble drugs. This review highlights several commercially or potentially commercially available nanoparticle engineering processes recently reported in the literature for increasing the dissolution properties of poorly water soluble drugs.

Citing Articles

Investigating the Effectiveness of Different Porous Nanoparticles as Drug Carriers for Retaining the Photostability of Pinosylvin Derivative.

Howaili F, Saadabadi A, Makila E, Korotkova E, Eklund P, Salo-Ahen O Pharmaceutics. 2024; 16(2).

PMID: 38399330 PMC: 10892027. DOI: 10.3390/pharmaceutics16020276.


Cancer-Specific Delivery of Proteolysis-Targeting Chimeras (PROTACs) and Their Application to Cancer Immunotherapy.

Moon Y, Jeon S, Shim M, Kim K Pharmaceutics. 2023; 15(2).

PMID: 36839734 PMC: 9965039. DOI: 10.3390/pharmaceutics15020411.


Celecoxib Nanoformulations with Enhanced Solubility, Dissolution Rate, and Oral Bioavailability: Experimental Approaches over In Vitro/In Vivo Evaluation.

Arslan A, Yet B, Nemutlu E, Akdag Cayli Y, Eroglu H, Oner L Pharmaceutics. 2023; 15(2).

PMID: 36839685 PMC: 9964073. DOI: 10.3390/pharmaceutics15020363.


Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics.

Bhalani D, Nutan B, Kumar A, Chandel A Biomedicines. 2022; 10(9).

PMID: 36140156 PMC: 9495787. DOI: 10.3390/biomedicines10092055.


Facile production of quercetin nanoparticles using 3D printed centrifugal flow reactors.

De Grandi D, Meghdadi A, Lutheryn G, Carugo D RSC Adv. 2022; 12(32):20696-20713.

PMID: 35919149 PMC: 9295137. DOI: 10.1039/d2ra02745c.